TITLE

Prevention of secondary cases of meningococcal disease in household contacts by vaccination

AUTHOR(S)
Greenwood, B.M.; Hassan-King, M.; Whittle, H.C.
PUB. DATE
May 1978
SOURCE
British Medical Journal;5/20/1978, Vol. 1 Issue 6123, p1317
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Household contacts of patients with group A meningococcal infection were vaccinated with either meningococcal vaccine or tetanus toxoid. Five of the 523 subjects who received tetanus toxoid developed meningococcal meningitis and another four probably had meningococcal disease. Only one possible case of meningococcal infection occurred among 520 contacts vaccinated with meningococcal vaccine. Vaccination had no effect on nasopharyngeal carriage of meningococci.
Vaccination of household contacts of patients with group A meningococcal infections is an effective way of rising limited supplies of meningococcal vaccine, though its value would be limited in an epidemic. Secondary cases of meningococcal infection often occur within a few days of the index case, and, although vaccine alone seemed to provide adequate prophylaxis in these Nigerian subjects, additional chemoprophylaxis may be needed to cover this critical period.
ACCESSION #
5420400

 

Related Articles

  • Influence of Prior Meningococcal C Polysaccharide Vaccination on the Response and Generation of Memory after Meningococcal C Conjugate Vaccination in Young Children. Borrow, Ray; Goldblatt, David; Andrews, Nick; Richmond, Peter; Southern, Joanna; Miller, Elizabeth // Journal of Infectious Diseases;8/1/2001, Vol. 184 Issue 3, p377 

    Presents a study which determined whether the immunological hyporesponsesiveness induced by meningococcal AC polysaccharide vaccine can be overcome by meningococcal C conjugate vaccine in children. Review of related literature; Characteristics of the participants; Materials and methods used;...

  • Group A and C meningococcal vaccines.  // Weekly Epidemiological Record;9/10/99, Vol. 74 Issue 36, p297 

    Examines the efficacy of group A and C meningococcal vaccines in controlling epidemics of meningococcal meningitis. Causes of meningococcal meningitis and septicemia; Use of vaccines in large-scale immunization programs; Number of mortality associated with meningococcal diseases.

  • Meningitis B vaccine looks promising. Sheldon, Tony // BMJ: British Medical Journal (International Edition);09/19/98, Vol. 317 Issue 7161, p770 

    Reveals that Dutch researchers believe that they have found an effective vaccine to combat group B meningococcal disease. Number of cases of bacterial meningitis in the Netherlands each year; Preliminary results of clinical trials with the vaccine; What most cases of meningococcal disease in...

  • Pipeline preview.  // Formulary;Nov2004, Vol. 39 Issue 11, p520 

    Updates on the U.S. Food & Drug Administration's actions on applications for drug approvals as of November 2004. Approval status of meningococcal polysaccharide diphtheria toxoid conjugate for vaccination against meningococcal disease; Drospirenone/estradiol for hormone replacement therapy;...

  • Low rate of adverse reactions for MeNZB. Topham-Kindley, Liane // New Zealand Doctor;9/21/2005, p3 

    Focuses on the general practice-based intensive meningococcal vaccine monitoring programme being conducted by the New Zealand Pharmacovigilance Centre. Significant events that have occurred during the programme; Number of reactions that have been reported through the spontaneous system; Purpose...

  • Vaccine for Meningococcal Meningitis Tested. Marwick, Charles // JAMA: Journal of the American Medical Association;10/16/91, Vol. 266 Issue 15, p2052 

    Reports on researchers at the U.S. National Institutes of Health's development of a vaccine that could immunize infants against meningococcal meningitis. Testing of the vaccine in mice; Lack of vaccines for meningococcal serotypes for infants; Ability of the vaccine to induce antibody to...

  • Meningococcal, influenza virus, and hepatitis B virus vaccination coverage level among health care workers in Hajj. Madani, Tariq A.; Ghabrah, Tawfik M. // BMC Infectious Diseases;2007, Vol. 7 Issue 1, p80 

    Background: The objective of this study was to assess the compliance of health care workers (HCWs) employed in Hajj in receiving the meningococcal, influenza, and hepatitis B vaccines. Methods: A cross-sectional survey of doctors and nurses working in all Mena and Arafat hospitals and primary...

  • Human papillomavirus vaccine recombinant quadrivalent/meningococcal vaccine groups A C Y W-135 conjugate.  // Reactions Weekly;5/17/2008, Issue 1202, p18 

    The article describes two cases of the development of syncope following treatment of human papillomavirus vaccine (HPV) recombinant quadrivalent/meningococcal vaccine A C Y W-135 conjugate. It references a study by A. Sutherland et al, published in the May 2008 issue of the "Morbidity and...

  • THE MEANING BEHIND MENINGITIS. McTaggart, Lynne // Ecologist;May2000, Vol. 30 Issue 3, p44 

    Criticizes the partnership between Great Britain's Department of Health and pharmaceutical company Wyeth for a mass vaccination campaign against the group C strain of meningococcal meningitis among children. Result of the tests conducted on anti-meningitis drug Meningitec; Causes of death among...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics